These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37799325)

  • 1. Immunologic Significance of CD80/CD86 or Major Histocompatibility Complex-II Expression in Thymic Epithelial Tumors.
    Ikeda H; Nagasaki J; Shimizu D; Katsuya Y; Horinouchi H; Hosomi Y; Tanji E; Iwata T; Itami M; Kawazu M; Ohe Y; Suzuki T; Togashi Y
    JTO Clin Res Rep; 2023 Oct; 4(10):100573. PubMed ID: 37799325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-12 neutralization alters lung inflammation and leukocyte expression of CD80, CD86, and major histocompatibility complex class II in mice infected with Histoplasma capsulatum.
    Cain JA; Deepe GS
    Infect Immun; 2000 Apr; 68(4):2069-76. PubMed ID: 10722603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and safety of immunotherapy in thymic epithelial tumors: more effective, more risky: a systematic review.
    Song X; Fan J; Zhu L; Wang Z; He Y; Zhou C
    J Thorac Dis; 2021 Aug; 13(8):5093-5103. PubMed ID: 34527346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and major histocompatibility complex class I and II molecules into human immunodeficiency virus type 1 virions and microvesicles: implications for viral pathogenesis and immune regulation.
    Esser MT; Graham DR; Coren LV; Trubey CM; Bess JW; Arthur LO; Ott DE; Lifson JD
    J Virol; 2001 Jul; 75(13):6173-82. PubMed ID: 11390619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of costimulatory molecules in the bovine corpus luteum.
    Cannon MJ; Davis JS; Pate JL
    Reprod Biol Endocrinol; 2007 Jan; 5():5. PubMed ID: 17266770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial Tumors.
    Song JS; Kim D; Kwon JH; Kim HR; Choi CM; Jang SJ
    Front Oncol; 2019; 9():1055. PubMed ID: 31681591
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression of MHC Class II, CD70, CD80, CD86 and pro-inflammatory cytokines is differentially regulated in oral epithelial cells following bacterial challenge.
    Han DC; Huang GT; Lin LM; Warner NA; Gim JS; Jewett A
    Oral Microbiol Immunol; 2003 Dec; 18(6):350-8. PubMed ID: 14622340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy of thymic epithelial tumors: molecular understandings and clinical perspectives.
    Ao YQ; Gao J; Wang S; Jiang JH; Deng J; Wang HK; Xu B; Ding JY
    Mol Cancer; 2023 Apr; 22(1):70. PubMed ID: 37055838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy in thymic epithelial tumors: tissue predictive biomarkers for immune checkpoint inhibitors.
    Lucà S; Accardo M; Campione S; Franco R
    Explor Target Antitumor Ther; 2024; 5(3):465-476. PubMed ID: 38966177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving treatment landscape in thymic epithelial tumors: From mechanism to therapy.
    Yang Y; Yu Y; Fan Y; Li H
    Biochim Biophys Acta Rev Cancer; 2024 Sep; 1879(5):189145. PubMed ID: 38942215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costimulatory molecules CD80 and CD86 in the rat; tissue distribution and expression by antigen-presenting cells.
    Damoiseaux JG; Yagita H; Okumura K; van Breda Vriesman PJ
    J Leukoc Biol; 1998 Dec; 64(6):803-9. PubMed ID: 9850164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal toxicity induced by anti-PD-1 immune checkpoint inhibitor in thymic epithelial tumor.
    Jing X; Zhu H; Li Y; Jia W; Zhai X; Li J; Yu J
    Immunotherapy; 2022 Oct; 14(14):1097-1107. PubMed ID: 36093721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphonuclear neutrophils in Wegener's granulomatosis acquire characteristics of antigen presenting cells.
    Iking-Konert C; Vogt S; Radsak M; Wagner C; Hänsch GM; Andrassy K
    Kidney Int; 2001 Dec; 60(6):2247-62. PubMed ID: 11737598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brief Report: High Levels of CD47 Expression in Thymic Epithelial Tumors.
    Sun TY; Nguyen B; Chen SB; Natkunam Y; Padda S; van de Rijn M; West R; Neal JW; Wakelee H; Riess JW
    JTO Clin Res Rep; 2023 Apr; 4(4):100498. PubMed ID: 37020927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of immune checkpoint inhibitors (ICIs) combined with antiangiogenic therapy for thymic epithelial tumors (TETs): a retrospective study.
    Xiang J; Si J; Hao Y; Wei J; Wang W; Guan Y; Xu C; Song Z
    Transl Cancer Res; 2023 Mar; 12(3):550-557. PubMed ID: 37033336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells.
    Tekguc M; Wing JB; Osaki M; Long J; Sakaguchi S
    Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of PD-L1 and other immunotherapeutic targets in thymic epithelial tumors.
    Arbour KC; Naidoo J; Steele KE; Ni A; Moreira AL; Rekhtman N; Robbins PB; Karakunnel J; Rimner A; Huang J; Riely GJ; Hellmann MD
    PLoS One; 2017; 12(8):e0182665. PubMed ID: 28771603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The differential role of CD86 and CD80 co-stimulatory molecules in the induction and the effector phases of contact hypersensitivity.
    Nuriya S; Yagita H; Okumura K; Azuma M
    Int Immunol; 1996 Jun; 8(6):917-26. PubMed ID: 8671681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human fibroblasts transduced with CD80 or CD86 efficiently trans-costimulate CD4+ and CD8+ T lymphocytes in HLA-restricted reactions: implications for immune augmentation cancer therapy and autoimmunity.
    Smythe JA; Fink PD; Logan GJ; Lees J; Rowe PB; Alexander IE
    J Immunol; 1999 Sep; 163(6):3239-49. PubMed ID: 10477593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of human non-small cell lung cancer (NSCLC) cell lines for expression of MHC, co-stimulatory molecules and tumor-associated antigens.
    Wroblewski JM; Bixby DL; Borowski C; Yannelli JR
    Lung Cancer; 2001; 33(2-3):181-94. PubMed ID: 11551413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.